Wellnex Life Ltd (22W0) Stock Price & Analysis
22W0 Stock Chart & Stats
- Day’s Range
- EUR 0.03 - EUR 0.03
- 52-Week Range
- EUR 0.01 - EUR 0.10
- Previous Close
- EUR 0.03
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 3.03M
- Enterprise Value
- EUR 12.18M
- Total Cash (Recent Filing)
- EUR 862.00K
- Total Debt (Recent Filing)
- EUR 9.68M
- Price to Earnings (P/E)
- ―
- Beta
- 1.95
- Next Earnings
- Mar 04, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound
The sustained revenue rebound over two fiscal years indicates improving scale and stronger commercial traction across Wellnex Life’s consumer healthcare activities. Continued top-line expansion can provide a broader base for operating leverage, brand investment, and eventual margin recovery if profitability improves.
Narrowing Losses
Narrowing losses show that the company has improved its earnings position from prior years, even though it has not reached profitability. This trend is a constructive foundation for future operating improvement, provided revenue growth can be retained and gross margins become more consistent.
Improving Balance Sheet And Cash Burn
Rebuilt equity and materially improved cash burn indicate progress from the extremely stressed FY2023 balance-sheet position. Although the company remains financially constrained, this strengthening gives Wellnex a more stable base from which to pursue growth and work toward sustainable cash generation.
Bears Say
Sharp Gross Margin Compression
The steep gross-margin decline demonstrates that revenue growth is not yet translating into durable economic value. Persistently weaker product-level profitability could restrict reinvestment, reduce operating leverage, and make the path to EBIT and EBITDA profitability substantially more difficult.
Persistent Negative Cash Flow
Continued operating cash outflows show that the business is not yet self-funding its operations. Persistent cash consumption increases dependence on external funding or balance-sheet resources, limiting financial flexibility until revenue growth and margins combine to produce sustainably positive cash flow.
Higher Leverage While Unprofitable
The sharp increase in debt relative to equity adds financial pressure while Wellnex remains loss-making and cash flow negative. Higher leverage can reduce flexibility for investment and make the company more exposed to funding constraints if profitability and operating cash generation do not improve.
Wellnex Life Ltd News
22W0 FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
What is Wellnex Life Ltd’s market cap?
When is Wellnex Life Ltd’s upcoming earnings report date?
How were Wellnex Life Ltd’s earnings last quarter?
Is Wellnex Life Ltd overvalued?
Does Wellnex Life Ltd pay dividends?
What is Wellnex Life Ltd’s EPS estimate?
How many shares outstanding does Wellnex Life Ltd have?
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Wellnex Life Ltd?
What is the TipRanks Smart Score and how is it calculated?
Wellnex Life Ltd Stock Smart Score
Company Description
Wellnex Life Ltd
Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.
- Sector
- Consumerdefensive
- Industry
- Packaged Foods
- CEO
- Eric Jiang
- Employees
- 3
- Website
- wellnexlife.com.au
- Address
- Port Park - Building 2, Port Melbourne, VIC, 3207, AU
Wellnex Life Ltd (22W0) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 5 | 2 | 3 |
| Moving Averages | 1 | 0 | 11 |
